Indeed, our findings identified altered glycosylation of two additional proteins not yet considered in the cancer coagulome, namely, thrombin (THRB) and coagulation factor X (FA10, Table 3), which should be evaluated for inclusion in the coagulome. The gene discussed is F10; the disease is cancer.